Cantel Medical Corp (CMD.N)
CMD.N on New York Stock Exchange
84.65USD
15 Feb 2019
84.65USD
15 Feb 2019
Change (% chg)
$2.13 (+2.58%)
$2.13 (+2.58%)
Prev Close
$82.52
$82.52
Open
$83.13
$83.13
Day's High
$85.07
$85.07
Day's Low
$83.13
$83.13
Volume
87,534
87,534
Avg. Vol
52,946
52,946
52-wk High
$130.92
$130.92
52-wk Low
$69.44
$69.44
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2019 | Oct | 225.59 | 0.482 |
| FY 2018 | Jul '18 | 228.85 | 0.411 |
| Apr '18 | 217.27 | 0.435 | |
| Jan '18 | 213.03 | 0.576 | |
| Oct | 212.77 | 0.548 | |
| FY 2017 | Jul '17 | 205.50 | 0.407 |
| Apr '17 | 192.11 | 0.419 | |
| Jan '17 | 184.82 | 0.432 | |
| Oct | 187.73 | 0.450 |
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Quarter Ending Oct-19 | 2 | 248.15 | 252.90 | 243.40 | -- |
| Quarter Ending Jan-19 | 4 | 226.95 | 228.80 | 225.10 | 238.11 |
| Year Ending Jul-19 | 5 | 941.92 | 964.00 | 929.70 | 987.61 |
| Year Ending Jul-20 | 5 | 1,030.80 | 1,081.00 | 1,000.20 | 1,103.39 |
| Earnings (per share) | |||||
| Quarter Ending Oct-19 | 2 | 0.67 | 0.69 | 0.65 | 0.75 |
| Quarter Ending Jan-19 | 3 | 0.62 | 0.62 | 0.62 | 0.64 |
| Year Ending Jul-19 | 4 | 2.63 | 2.76 | 2.58 | 2.84 |
| Year Ending Jul-20 | 4 | 2.99 | 3.26 | 2.86 | 3.17 |
Sales and Profit Figures in US Dollar (USD);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | 56.96 | 32.21 | 33.70 | |
| P/E High - Last 5 Yrs. | 47.58 | 40.37 | 49.87 | |
| P/E Low - Last 5 Yrs. | 27.86 | 19.61 | 24.25 | |
| Beta | 1.22 | 0.79 | 0.90 | |
| Price to Sales (TTM) | 5.27 | 6.69 | 6.29 | |
| Price to Book (MRQ) | 7.75 | 4.95 | 5.26 | |
| Price to Tangible Book (MRQ) | 46.14 | 16.59 | 6.77 | |
| Price to Cash Flow (TTM) | 38.72 | 21.70 | 24.98 | |
| % Owned Institutions | 86.64 | 4.68 | 1.69 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | 0.14 | 1.05 | 1.40 | |
| Dividend Yield - 5 Year Avg | 0.21 | 1.26 | 1.42 | |
| Dividend 5 Year Growth Rate | 15.07 | 16.24 | 4.85 | |
| Payout Ratio(TTM) | 0.00 | 30.85 | 41.03 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 14.80 | 8.67 | 12.75 | |
| Sales (TTM) vs TTM 1 Yr. Ago | 15.86 | 2.19 | 5.84 | |
| Sales - 5 Yr. Growth Rate | 14.79 | 8.65 | 11.23 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 4.19 | 59.77 | 47.15 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 18.87 | -- | -- | |
| EPS - 5 Yr. Growth Rate | 17.32 | 19.62 | 10.85 | |
| Capital Spending - 5 Yr. Growth Rate | 37.52 | 7.92 | 15.20 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | 1.49 | 2.44 | 2.25 |
| Current Ratio (MRQ) | 2.41 | 3.17 | 3.08 |
| LT Debt to Equity (MRQ) | 24.05 | 29.53 | 11.38 |
| Total Debt to Equity (MRQ) | 24.05 | 36.50 | 16.12 |
| Interest Coverage (TTM) | 31.31 | 15.21 | 29.47 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | 47.72 | 58.80 | 53.81 | |
| Gross Margin - 5 Yr. Avg. | 45.67 | 58.29 | 52.18 | |
| EBITD Margin (TTM) | 19.80 | -- | -- | |
| EBITD - 5 Yr. Avg | 19.23 | 22.93 | 12.87 | |
| Operating Margin (TTM) | 14.34 | 17.67 | 6.20 | |
| Operating Margin - 5 Yr. Avg. | 14.43 | 15.83 | 8.31 | |
| Pre-Tax Margin (TTM) | 13.79 | 17.43 | 7.16 | |
| Pre-Tax Margin - 5 Yr. Avg. | 13.91 | 16.09 | 8.61 | |
| Net Profit Margin (TTM) | 9.27 | 13.32 | 3.30 | |
| Net Profit Margin - 5 Yr. Avg. | 8.98 | 11.24 | 4.89 | |
| Effective Tax Rate (TTM) | 32.81 | 23.16 | 22.91 | |
| Effective Tax Rate - 5 Yr. Avg. | 35.41 | 28.89 | 23.38 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 329,549 | 28,762,491 | 842,398,385 | |
| Net Income/Employee (TTM) | 30,543 | 3,194,057 | 99,842,801 | |
| Receivable Turnover (TTM) | 7.55 | 5.08 | 5.71 | |
| Inventory Turnover (TTM) | 4.23 | 3.28 | 3.47 | |
| Asset Turnover (TTM) | 1.04 | 0.79 | 0.93 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | 9.64 | 10.47 | 11.06 | |
| Return on Assets - 5 Yr. Avg. | 8.99 | 8.98 | 12.20 | |
| Return on Investment (TTM) | 11.17 | 13.74 | 14.45 | |
| Return on Investment - 5 Yr. Avg. | 10.31 | 11.63 | 15.87 | |
| Return on Equity (TTM) | 14.50 | 16.49 | 15.96 | |
| Return on Equity - 5 Yr. Avg. | 13.31 | 13.95 | 17.00 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | 15.86 | 16.37 | 14.79 |
| EPS (TTM) % | 18.87 | 17.85 | 17.32 |
| Dividend % | -18.75 | 16.60 | 15.07 |
Note: Units in Millions of US Dollars
Performance for Cantel Medical Corp
| Period | % Actual |
% vs. S&P 500 |
Rank In Industry |
Industry Rank |
|---|---|---|---|---|
| 4 Week | 18.42 | 14.33 | 99 | 52 |
| 13 Week | 29.19 | 22.90 | 99 | 72 |
| 26 Week | 31.51 | 21.52 | 99 | 63 |
| 52 Week | 23.17 | 4.40 | 99 | 42 |
| YTD | 23.53 | 8.48 | 99 | 39 |
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 88.48% |
| # of Holders: | 341 |
| Total Shares Held: | 36,913,754 |
| 3 Mo. Net Change: | -482,915 |
| # New Positions: | 30 |
| # Closed Positions: | 68 |
| # Increased Positions: | 135 |
| # Reduced Positions: | 194 |
| # Net Buyers: | -59 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.